EPIRIUM BIO ANNOUNCES FOLLOW-ON PHASE 1 RESULTS IN OLDER ADULT PARTICIPANTS FOR MF-300, A FIRST-IN-CLASS, ORAL 15-PGDH ENZYME INHIBITOR, FOR THE TREATMENT OF SARCOPENIA

Reuters · 4d ago

Please log in to view news